Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VivaMed
Campbell, California, United Statesvivamed.us ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
VivaMed is a medical device company, part of the InCube Labs portfolio, focused on developing a minimally invasive, catheter-based neuromodulation therapy for the treatment of heart failure. The company's proprietary VivaMed System targets the carotid sinus to modulate the autonomic nervous system, aiming to restore balance and improve cardiac function in patients with heart failure with reduced ejection fraction (HFrEF). By utilizing a catheter-based approach, VivaMed seeks to provide a less invasive alternative to traditional surgical baroreflex activation therapies. The technology is designed to reduce the overactivity of the sympathetic nervous system, which is a hallmark of heart failure progression.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceNeuromodulation
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on VivaMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VivaMed.